• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP 0.00% 18.0¢

CYNATA THERAPEUTICS LIMITED

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP
Going forward...
34 35 36
18/03/24 2.1K 664K
18/03/24 Last post  gavint66 Comments Created with Sketch.  2.1K  Views Created with Sketch.  664K 
CYP 18/03/24 0 247
18/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  247 
CYP
The Phase I/IIb Nereid Study Is Now Registered
14/03/24 17 2.4K
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
14/03/24 Last post  Artephius Comments Created with Sketch.  17  Views Created with Sketch.  2.4K 
CYP
CYP chart
31 32 33
08/03/24 1.9K 574K
08/03/24 Last post  nippy Comments Created with Sketch.  1.9K  Views Created with Sketch.  574K 
CYP 07/03/24 36 5.7K
07/03/24 Last post  truss20 Comments Created with Sketch.  36  Views Created with Sketch.  5.7K 
CYP 02/03/24 6 1.9K
02/03/24 Last post  gavint66 Comments Created with Sketch.  6  Views Created with Sketch.  1.9K 
CYP 29/02/24 49 9.3K
29/02/24 Last post  Doug Diamond Comments Created with Sketch.  49  Views Created with Sketch.  9.3K 
CYP
TA
26/02/24 20 4.8K
26/02/24 Last post  col69 Comments Created with Sketch.  20  Views Created with Sketch.  4.8K 

See All Discussions arrow Created with Sketch.

Timeline

Cynata Presenting at Advanced Therapies Congress
18 Mar 08:52
 
First Patient Treated in Phase 2 GvHD Trial
05 Mar 08:54
 
Cynata Appoints New Chief Business Officer
29 Feb 09:19
 
Encouraging Initial Data from CYP-006TK DFU Trial
26 Feb 09:01
 
Appendix 4D & Half-Year Financial Statements
23 Feb 15:22
 
Quarterly Activity Report & Appendix 4C
30 Jan 08:56
 
View More arrow Created with Sketch.
(20min delay)
Last
18.0¢
Change
0.000(0.00%)
Mkt cap ! $32.33M
Open High Low Value Volume
18.0¢ 18.0¢ 18.0¢ $4.5K 25K

Buyers (Bids)

No. Vol. Price($)
2 17079 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 67736 6
View Market Depth
Last trade - 10.13am 19/03/2024 (20 minute delay) ?
Last
17.0¢
  Change
0.000 ( 0.47 %)
Open High Low Volume
17.0¢ 17.0¢ 17.0¢ 923
Last updated 14.57pm 19/03/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.